TITLE

Editorial

AUTHOR(S)
Creager MD, M.A.; Anand, S.S.
PUB. DATE
February 2001
SOURCE
Vascular Medicine;2001, Vol. 6 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
abstract
ACCESSION #
4386920

 

Related Articles

  • Wide-sweeping results with butcher's broom. R.M.D. // Cortlandt Forum;12/20/95, Vol. 8 Issue 12, p63 

    Focuses on the use of butcher's broom in treatment of vascular diseases. Butcher's broom's properties.

  • Pulsed dye lasers advance treatment of vascular lesions. Benson, Linda R. // Dermatology Times;Jan1998, Vol. 19 Issue 1, p54 

    Evaluates the efficacy of pulsed dye lasers for the advance treatment of vascular lesions. Medical benefits of pulsed dye lasers; Variety of pulsed lasers available; Features of pulse dye laser technology.

  • Does felodipine improve circulation in peripheral vascular disease?  // Age & Ageing;May98, Vol. 27 Issue 3, p266 

    Provides information on an article appearing in the periodical `Vascular Medicine' volume 2, investigating whether felodipine improves circulation in peripheral vascular disease.

  • Peripheral arterial disease: 5 steps to a better outcome. Donaldson, Magruder C.; Olin, Jeffrey W. // Patient Care;1/15/1996, Vol. 30 Issue 1, p22 

    Offers advice for physicians on treating peripheral arterial disease. Need to increase awareness of the prevalence and clinical significance of the disease; Tips on improving knowledge on the diagnosis of the disease; Understanding the value of structured exercise programs; Tips on referring...

  • Pentoxifylline Studies.  // Life Extension;Jan2002, Vol. 8 Issue 1, p18 

    Provides information on pentoxifylline (PTX), a prescription drug approved by the U.S. Food and Drug Administration to treat peripheral vascular disease. Standard dosage; Findings of a controlled study on human diabetics with advanced renal failure; Effect of PTX in a group of pediatric lupus...

  • Widespread ACE inhibitor use justified in vascular disease, HOPE study reveals.  // Formulary;Oct99, Vol. 34 Issue 10, p819 

    Recommends the expansion use of Angiotensin Converting Enzyme (ACE) inhibitors to all patients with vascular disease. Lead investigator of the Heart Outcomes Protection Evaluation study; Number of countries and patients involved in the study of ACE inhibitors; Benefits from the use of the...

  • DEB adoption on the rise in Europe.  // Medical Device Daily;7/5/2011, Vol. 15 Issue 122, p9 

    The article reports on the growing number of European doctors who use drug-eluting balloons (DEBs) in peripheral vascular treatment, according to the Millennium Research Group.

  • Standard exercise test to assess peripheral arterial disease. Laing, Susan P.; Greenhalgh, Roger M. // British Medical Journal;1/5/1980, Vol. 280 Issue 6206, p13 

    Assesses peripheral arterial disease via standard exercise test. Indications of severity of hemodynamics; Effects of workloads on pressure response; Measurement of disability by claudication distance.

  • Recent Report Predicts Significant Opportunity for Bioabsorbable Scaffold Market.  // Medical Product Outsourcing;Sep2015, Vol. 13 Issue 7, p34 

    The article focuses on the findings of a research conducted by GlobalData which shows that the worldwide market value for bioabsorbable scaffolds (BAS) is expected to expand driven by new product approvals in the clinical treatment of vascular diseases toward minimally invasive procedures.

  • Selected Phlébologie Abstracts.  // Phlebology;Mar2014, Vol. 29 Issue 2, p129 

    The article presents abstracts on medical topics which include history of endovenous techniques for treating varices, ablation of varices using endovenous laser treatment, and cartography of endovenous laser treatment.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics